Write your message
Volume 16, Issue 2 (May 2022)                   IJT 2022, 16(2): 99-112 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Banke Idris S, Abdul Kadir A, Faez Firdaos Abdullah J, Ramanoon S, Abdul Basit M, Zuki Zackariah Abubakar M. Efficacy and Toxicity Studies of Oxytetracycline-loaded Calcium Carbonate Nanoparticles in Corynebacterium pseudotuberculosis Infected BALB/C Mice. IJT. 2022; 16 (2) :99-112
URL: http://ijt.arakmu.ac.ir/article-1-1062-en.html
1- Department of Veterinary Preclinical Studies, Faculty of Veterinary Medicine, University Putra Malaysia, Serdang, Malaysia.
2- Department of Veterinary Preclinical Studies, Faculty of Veterinary Medicine, University Putra Malaysia, Serdang, Malaysia. , arifah@upm.edu.my
3- Department of Veterinary Clinical Studies, Faculty of Veterinary Medicine, University Putra Malaysia, Serdang, Malaysia.
4- Department of Farm and Exotic Animal Medicine and Surgery, Faculty of Veterinary Medicine, University Putra Malaysia, Serdang, Malaysia.
Abstract:   (326 Views)
Background: Caseous Lymphadenitis (CLA) is an important bacterial disease in goats, caused by Corynebacterium pseudotuberculosis. The disease is highly prevalent worldwide and causes significant economic losses to the cattle industry. Currently, the treatment of this disease with antibiotics remains largely unsuccessful due to the nature of the bacteria and the resultant resistance to the drugs.
Methods: Thirty apparently healthy female BALB/c mice, aged 5-6 weeks old were used to assess the efficacy of oxytetracycline loaded in calcium carbonate nanoparticle (OTC-CS-CaCO3NP) and toxicity of calcium carbonate nanoparticle (CS-CaCO3NP). The mice were randomly divided into five groups of six each and were exposed to the following treatments: Group 1: received sterile distilled water; Group 2: received 0.2 ml C. pseudotuberculosis; Group 3: received 0.2 ml C. pseudotuberculosis and 10mg/kg OTC; Group 4: was given 0.2 ml C. pseudotuberculosis and 10mg/kg OTC-CS-CaCO3NP; and Group 5: was administered 20mg/kg CS-CaCO3NP. 
Results: The clinical signs of infection with C. pseudotuberculosis in the mice were significantly reduced after treatment with OTC-CS-CaCO3NP. The haematology results showed an insignificant reduction in the mean RBC count, Hb and haematocrit levels in Group 2 (infected controls) compared to the mice treated with oxytetracycline loaded nanoparticles. The biochemical analyses revealed no significant changes among the treatment groups. No histopathological lesions were found in the organs of the mice, treated with 20mg/kg CS-CaCO3NP, suggesting the absence of toxicity in vivo.
Conclusion: The results from this study indicate the potentials of OTC-CS-CaCO3NP as becoming a nano-antibiotic formulation for the treatment of caseous lymphadenitis infection in mice.
Full-Text [PDF 2821 kb]   (126 Downloads) |   |   Full-Text (HTML)  (19 Views)  
Type of Study: Research | Subject: General

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | Iranian Journal of Toxicology

Designed & Developed by : Yektaweb